Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
70.92
-1.91 (-2.62%)
Jun 3, 2025, 3:28 PM - Market open
Novo Nordisk Employees
As of December 31, 2024, Novo Nordisk had 77,349 total employees, including 76,302 full-time and 1,047 part-time employees. The number of employees increased by 13,030 or 20.26% compared to the previous year.
Employees
77,349
Change (1Y)
13,030
Growth (1Y)
20.26%
Revenue / Employee
$567,845
Profits / Employee
$195,965
Market Cap
315.80B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 77,349 | 13,030 | 20.26% |
Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
Eli Lilly and Company | 47,000 |
NVO News
- 5 days ago - Novo Nordisk's weight-loss drug Wegovy has been surpassed in weekly U.S. prescriptions by Eli Lilly's Zepbound, and now the company is trying to get back on track - WSJ
- 6 days ago - Novo Nordisk's Buy Scenario Is Supported By Quantitative Evidence - Seeking Alpha
- 7 days ago - Weight-loss drugs like Ozempic and Wegovy continue to be in high demand—and expensive. Are prices likely to come down soon? - WSJ
- 8 days ago - Is Novo Nordisk Immune To President Trump's Drug Price Plans - Seeking Alpha
- 8 days ago - Should everyone be taking drugs like Ozempic? Drugs in the GLP-1-category show promise for a growing list of health conditions - WSJ
- 11 days ago - Novo Nordisk's High Risk/Reward Proposition: 129% Rally Or 65% Drop? - Benzinga
- 12 days ago - Novo Nordisk offers Wegovy for $199 for first month to new cash-paying customers - Reuters
- 12 days ago - New Novo Nordisk initiatives support patient access to authentic, FDA-approved Wegovy® as federal ban on mass compounding of "semaglutide" takes effect - PRNewsWire